Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Conti

Showing results (191-200 of 346) with videos related to

Pageof 35
Sort By:
Current Neuropharmacology|June 26, 2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two CasesChiara Cambieri, Marco Marenco, Tania Colasanti, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational studyRossana Scrivo, Chiara Castellani, Silvia Mancuso, et al.
Autoimmunity Reviews|March 25, 2014
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid SyndromeRicard Cervera, Ignasi Rodríguez-Pintó, Serena Colafrancesco, et al.
Plos One|March 23, 2017
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Clinical and Experimental Medicine|May 1, 2025
Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal studyClaudia Ciancarella, Fulvia Ceccarelli, Licia Picciariello, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional studyFulvia Ceccarelli, Valeria Orefice, Giuseppina Perrone, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell responseFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Plos One|December 5, 2018
Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Clinical Immunology (Orlando, Fla.)|February 18, 2016
Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritisZahava Vadasz, Yair Goldeberg, Katty Halasz, et al.
Pageof 35

Showing results (191-200 of 346) with videos related to

Sort By:
Pageof 35
Current Neuropharmacology|June 26, 2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two CasesChiara Cambieri, Marco Marenco, Tania Colasanti, et al.
Clinical and Experimental Rheumatology|August 2, 2022
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational studyRossana Scrivo, Chiara Castellani, Silvia Mancuso, et al.
Autoimmunity Reviews|March 25, 2014
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid SyndromeRicard Cervera, Ignasi Rodríguez-Pintó, Serena Colafrancesco, et al.
Plos One|March 23, 2017
Prediction of chronic damage in systemic lupus erythematosus by using machine-learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Clinical and Experimental Medicine|May 1, 2025
Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal studyClaudia Ciancarella, Fulvia Ceccarelli, Licia Picciariello, et al.
Clinical and Experimental Rheumatology|February 22, 2020
Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional studyFulvia Ceccarelli, Valeria Orefice, Giuseppina Perrone, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell responseFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
Plos One|December 5, 2018
Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning modelsFulvia Ceccarelli, Marco Sciandrone, Carlo Perricone, et al.
Clinical Immunology (Orlando, Fla.)|February 18, 2016
Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritisZahava Vadasz, Yair Goldeberg, Katty Halasz, et al.
Pageof 35